Skip to search formSkip to main contentSkip to account menu

pRL1a protein, mouse

Known as: IPGLPLSL, Ile-Pro-Gly-Leu-Pro-Leu-Ser-Leu, isoleucyl-prolyl-glycyl-leucyl-prolyl-leucyl-seryl-leucine 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Antigens, NeoplasmOligopeptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Vaccination with multiple antigen peptide as rejection antigen peptide in murine leukemia.
pRL1a (IPGLPLSL) is the Ld-binding tumor rejection antigen peptide recognized by CTLs on BALB/c radiation leukemia RL(male)1. We… 
1997
1997
Diversity of epitopes recognized by cytotoxic T lymphocytes that are specific for rejection antigen peptide pRL1a presented on BALB/c leukemia RL Male 1.
Cytotoxic T lymphocytes (CTL) generated in (BALB/c x C57BL/6)F1 (CB6F1) and BALB/c spleen cells stimulated with BALB/c radiation… 
1996
1996
Production of Murine Leukemia RL♂1 Rejection Antigen Peptide pRL1a by Proteolysis of Natural Precursor pRL1b
In this study, we demonstrated that NH2‐terminal Ser and Ile residues of pRL1b (SI‐pRL1a) (SIIPGLPLSL) are not involved in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)